That's not how the ruling would work, though.
The administration would remain free to respond to its mess as it sees fit, even if the FDA approval had been called out as failing to follow procedure.
IF mifepristone is unavailable, it would be because the executive branch chose, for itself, to crack down on it instead of approving it properly.